Lilly Reports Strong Fourth-Quarter and Full-Year 2019 Financial Results, Updates 2020 Guidance for Pending Dermira Acquisition

Go back to Lilly Reports Strong Fourth-Quarter and Full-Year 2019 Financial Results, Updates 2020 Guidance for Pending Dermira Acquisition
eLandia International, Inc. (NYSE: ELAN) Delayed: 23.18 --0 (-0%)
Previous Close $23.18    52 Week High $0.65 
Open $23.18    52 Week Low $0.03 
Day High $23.18    P/E N/A 
Day Low $23.18    EPS $-0.60 
Volume 2,332       

Lilly (Eli) & Co. (NYSE: LLY) Delayed: 1107.08 --0 (-0%)
Previous Close $1107.08    52 Week High $88.16 
Open $1107.08    52 Week Low $67.88 
Day High $1107.08    P/E 256.27 
Day Low $1107.08    EPS $4.32 
Volume 1,924